As of Feb 12
| -0.69 / -4.92%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 28.00 and a low estimate of 18.00. The median estimate represents a +49.93% increase from the last price of 13.34.
The current consensus among 9 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.